Medicare Enrolled

Dr. Luis Polo, NP

Physician Assistant · Savannah, GA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
1115 LEXINGTON AVE, Savannah, GA 31404
9123544813
In practice since 2017 (9 years)
NPI: 1831624899 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Polo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Polo? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Polo

Dr. Luis Polo is a physician assistant in Savannah, GA, with 9 years of NPI registration. Based on federal Medicare data, Dr. Polo performed 130 Medicare services across 111 unique beneficiaries.

Between the years covered by Open Payments, Dr. Polo received a total of $62,964 from 31 pharmaceutical and/or device companies across 340 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in physician assistant. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Polo is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 9 years in practice ▲ 130 Medicare services $62,964 industry payments

Medicare Practice Summary

Medicare Utilization ↗
130
Medicare services
Bottom 35% in GA for physician assistant
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
111
Unique beneficiaries
$132
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~14 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Dialysis services for adults, 2-3 visits per month
This code covers dialysis services for patients aged 20 or older who have 2 to 3 physician visits per month.
56 $183 $786
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
34 $63 $298
Monthly dialysis physician visit
A monthly doctor's visit for patients aged 20 or older who are receiving dialysis treatment.
22 $129 $509
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
18 $105 $401
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$62,964
Total received (2021-2024)
Avg $15,741/year across 4 years
Top 0% in GA for physician assistant
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
31
Companies
340
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$57,535 (91.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,429 (8.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$15,982
2023
$22,968
2022
$9,012
2021
$15,002

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$8,875
AstraZeneca Pharmaceuticals LP
$5,388
Ardelyx, Inc.
$242
Aurinia Pharma U.S., Inc.
$213
Vifor Pharma, Inc.
$205
Travere Therapeutics, Inc.
$168
Otsuka America Pharmaceutical, Inc.
$138
Averitas Pharma Inc.
$137
Otsuka Pharmaceutical Development & Commercialization, Inc.
$109
Novartis Pharmaceuticals Corporation
$108
Mallinckrodt Hospital Products Inc.
$88
Boehringer Ingelheim Pharmaceuticals, Inc.
$76
CALLIDITAS THERAPEUTICS US INC.
$60
Bayer Healthcare Pharmaceuticals Inc.
$49
Lilly USA, LLC
$44
Nevro Corp.
$29
AKEBIA THERAPEUTICS INC
$26
Fresenius USA Marketing, Inc.
$24
Top 3 companies account for 90.8% of 2024 payments
All-time payments by company (2021-2024) ›
AstraZeneca Pharmaceuticals LP
$31,865
Horizon Therapeutics plc
$16,692
Amgen Inc.
$9,054
Aurinia Pharma U.S., Inc.
$922
Vifor Pharma, Inc.
$879
Mallinckrodt Hospital Products Inc.
$772
Otsuka America Pharmaceutical, Inc.
$300
Ardelyx, Inc.
$277
Travere Therapeutics, Inc.
$251
OPKO Pharmaceuticals, LLC
$228
Bayer HealthCare Pharmaceuticals Inc.
$192
Bayer Healthcare Pharmaceuticals Inc.
$186
Alexion Pharmaceuticals, Inc.
$146
Averitas Pharma Inc.
$137
Otsuka Pharmaceutical Development & Commercialization, Inc.
$109
Novartis Pharmaceuticals Corporation
$108
Novo Nordisk Inc
$96
Pharmacosmos Therapeutics Inc.
$96
Boehringer Ingelheim Pharmaceuticals, Inc.
$95
Fresenius USA Marketing, Inc.
$86
CALLIDITAS THERAPEUTICS US INC.
$76
Calliditas Therapeutics US Inc.
$72
AKEBIA THERAPEUTICS INC
$62
Lilly USA, LLC
$62
Galderma Laboratories, L.P.
$56
Ultragenyx Pharmaceutical Inc.
$41
Nevro Corp.
$29
Takeda Pharmaceuticals U.S.A., Inc.
$24
GlaxoSmithKline, LLC.
$18
Leadiant Biosciences, Inc.
$18
Alnylam Pharmaceuticals Inc.
$17
Top 3 companies account for 91.5% of all-time payments
Associated products mentioned in payments ›
ACTHAR · Auryxia · BENLYSTA · Carnitor · Crysvita · FARXIGA · Fabhalta · GATTEX · GIVLAARI · IBSRELA · JARDIANCE · JYNARQUE · KRYSTEXXA · Kerendia · Korsuva · LOKELMA · LUPKYNIS · MONOFERRIC · QUTENZA · RAYALDEE · Senza · TARPEYO · TAVNEOS · TERLIVAZ · Tavneos · Thiola · ULTOMIRIS · Ultomiris · Velphoro · Veltassa · XPHOZAH 30 MG
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (91%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in physician assistant and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for physician assistant in GA.

Looking for a physician assistant in Savannah?
Compare physician assistants in the Savannah area by procedure volume, costs, and industry payment transparency.
Browse physician assistants nearby

Geographic Context

Physician assistants within 10 mi
151
Per 100K population
50.6
County median income
$69,575
Nearest hospital
SAVANNAH HEALTH SERVICES LLC DBA MEMORIAL HEALTH UNIVERSITY MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Polo is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 0% of GA peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Polo experienced with dialysis services for adults, 2-3 visits per month?
Based on Medicare claims data, Dr. Polo performed 56 dialysis services for adults, 2-3 visits per month services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Polo receive payments from pharmaceutical companies?
Yes. Dr. Polo received a total of $62,964 from 31 companies across 340 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Polo's costs compare to other physician assistants in Savannah?
Dr. Polo's average Medicare payment per service is $132. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Polo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →